EFS benefit is seen with sasanlimab in CIS and T1 NMIBC
Perioperative sacituzumab govitecan/pembro yields compelling CR rate in MIBC
Interim ENLIGHTED data show promise for padeliporfin VTP therapy in UTUC
PEACE-3 data for radium-223/enzalutamide published in Annals of Oncology